Page last updated: 2024-08-18

pyrazolanthrone and rimorphin

pyrazolanthrone has been researched along with rimorphin in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Bruchas, MR; Chavkin, C; Defino, M; Kwan, SC; Li, S; Schreiber, S; Yang, T	1

Other Studies

1 other study(ies) available for pyrazolanthrone and rimorphin

Article	Year
Long-acting kappa opioid antagonists disrupt receptor signaling and produce noncompetitive effects by activating c-Jun N-terminal kinase. The Journal of biological chemistry, 2007, Oct-12, Volume: 282, Issue:41 Topics: 3,4-Dichloro-N-methyl-N-(2-(1-pyrrolidinyl)-cyclohexyl)-benzeneacetamide, (trans)-Isomer; Analgesics, Non-Narcotic; Animals; Anthracenes; Enzyme Activation; Enzyme Inhibitors; Humans; JNK Mitogen-Activated Protein Kinases; Kinetics; Mice; Mice, Knockout; Models, Biological; Phosphorylation; Receptors, Opioid, kappa; Signal Transduction	2007

Article

Year

Long-acting kappa opioid antagonists disrupt receptor signaling and produce noncompetitive effects by activating c-Jun N-terminal kinase.

The Journal of biological chemistry, 2007, Oct-12, Volume: 282, Issue:41

Topics: 3,4-Dichloro-N-methyl-N-(2-(1-pyrrolidinyl)-cyclohexyl)-benzeneacetamide, (trans)-Isomer; Analgesics, Non-Narcotic; Animals; Anthracenes; Enzyme Activation; Enzyme Inhibitors; Humans; JNK Mitogen-Activated Protein Kinases; Kinetics; Mice; Mice, Knockout; Models, Biological; Phosphorylation; Receptors, Opioid, kappa; Signal Transduction

2007